{
  "submissionSets": [
    {
      "Patient Name": "001-001 FDG 1 Regional^4277^6688^^",
      "Patient ID": "001-001 FDG 1 Regional",
      "Accession Number": "0",
      "Study Date": "20091110",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FDG 2 Regional^4277^6688^^",
      "Patient ID": "001-001 FDG 2 Regional",
      "Accession Number": "0",
      "Study Date": "20100107",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FDG 2 WB^4277^6688^^",
      "Patient ID": "001-001 FDG 2 WB",
      "Accession Number": "0",
      "Study Date": "20100107",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FDG 3 Regional^4277^6688^^",
      "Patient ID": "001-001 FDG 3 Regional",
      "Accession Number": "0",
      "Study Date": "20100217",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FLT 1 Dynamic^4277^6688^^",
      "Patient ID": "001-001 FLT 1 Dynamic",
      "Accession Number": "0",
      "Study Date": "20091113",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FLT 1 WB(2hr)^4277^6688^^",
      "Patient ID": "001-001 FLT 1 WB(2hr)",
      "Accession Number": "0",
      "Study Date": "20091113",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FLT 1 WB^4277^6688^^",
      "Patient ID": "001-001 FLT 1 WB",
      "Accession Number": "0",
      "Study Date": "20091113",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001 FLT 3^4277^6688^^",
      "Patient ID": "001-001 FLT 3",
      "Accession Number": "0",
      "Study Date": "20100218",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001^4277^6688^^",
      "Patient ID": "001-001",
      "Accession Number": "0",
      "Study Date": "20100218",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001^4277^6688^^",
      "Patient ID": "001-001",
      "Accession Number": "0",
      "Study Date": "20100217",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001^4277^6688^^",
      "Patient ID": "001-001",
      "Accession Number": "0",
      "Study Date": "20100113",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-001^4277^6688^^",
      "Patient ID": "001-001",
      "Accession Number": "0",
      "Study Date": "20091110",
      "parameters": [
        {
          "Case Number": "1",
          "Enrollment Date": "20091110",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002 FDG 1 Regional^4277^6688^^",
      "Patient ID": "001-002 FDG 1 Regional",
      "Accession Number": "0",
      "Study Date": "20100118",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002 FDG 1^4277^6688^^",
      "Patient ID": "001-002 FDG 1",
      "Accession Number": "0",
      "Study Date": "20100118",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002 FLT 1 WB^4277^6688^^",
      "Patient ID": "001-002 FLT 1 WB",
      "Accession Number": "0",
      "Study Date": "20100120",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002^4277^6688^^",
      "Patient ID": "001-002",
      "Accession Number": "0",
      "Study Date": "20100310",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002^4277^6688^^",
      "Patient ID": "001-002",
      "Accession Number": "0",
      "Study Date": "20100308",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-002^4277^6688^^",
      "Patient ID": "001-002",
      "Accession Number": "0",
      "Study Date": "20100120",
      "parameters": [
        {
          "Case Number": "2",
          "Enrollment Date": "20100118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-003^4277^6688^^",
      "Patient ID": "001-003",
      "Accession Number": "0",
      "Study Date": "20100819",
      "parameters": [
        {
          "Case Number": "3",
          "Enrollment Date": "20100323",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-003^4277^6688^^",
      "Patient ID": "001-003",
      "Accession Number": "0",
      "Study Date": "20100525",
      "parameters": [
        {
          "Case Number": "3",
          "Enrollment Date": "20100323",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-003^4277^6688^^",
      "Patient ID": "001-003",
      "Accession Number": "0",
      "Study Date": "20100324",
      "parameters": [
        {
          "Case Number": "3",
          "Enrollment Date": "20100323",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-003^4277^6688^^",
      "Patient ID": "001-003",
      "Accession Number": "0",
      "Study Date": "20100323",
      "parameters": [
        {
          "Case Number": "3",
          "Enrollment Date": "20100323",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004 FDG 2^4277^6688^^",
      "Patient ID": "001-004 FDG 2",
      "Accession Number": "0",
      "Study Date": "20100629",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004 FLT 2 WB (2hr)^4277^6688^^",
      "Patient ID": "001-004 FLT 2 WB (2hr)",
      "Accession Number": "0",
      "Study Date": "20100630",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004^4277^6688^^",
      "Patient ID": "001-004",
      "Accession Number": "0",
      "Study Date": "20100630",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004^4277^6688^^",
      "Patient ID": "001-004",
      "Accession Number": "0",
      "Study Date": "20100629",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004^4277^6688^^",
      "Patient ID": "001-004",
      "Accession Number": "0",
      "Study Date": "20100427",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-004^4277^6688^^",
      "Patient ID": "001-004",
      "Accession Number": "0",
      "Study Date": "20100426",
      "parameters": [
        {
          "Case Number": "4",
          "Enrollment Date": "20100427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20101028",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20101027",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20100818",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20100811",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20100506",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-005^4277^6688^^",
      "Patient ID": "001-005",
      "Accession Number": "0",
      "Study Date": "20100429",
      "parameters": [
        {
          "Case Number": "5",
          "Enrollment Date": "20100429",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-006 FLT 1 WB(2Hr)^4277^6688^^",
      "Patient ID": "001-006 FLT 1 WB(2Hr)",
      "Accession Number": "0",
      "Study Date": "20100524",
      "parameters": [
        {
          "Case Number": "6",
          "Enrollment Date": "20100524",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-006 FLT 1WB(1hr)^4277^6688^^",
      "Patient ID": "001-006 FLT 1WB(1hr)",
      "Accession Number": "0",
      "Study Date": "20100524",
      "parameters": [
        {
          "Case Number": "6",
          "Enrollment Date": "20100524",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-007^4277^6688^^",
      "Patient ID": "001-007",
      "Accession Number": "0",
      "Study Date": "20101013",
      "parameters": [
        {
          "Case Number": "9",
          "Enrollment Date": "20100728",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-007^4277^6688^^",
      "Patient ID": "001-007",
      "Accession Number": "0",
      "Study Date": "20100729",
      "parameters": [
        {
          "Case Number": "9",
          "Enrollment Date": "20100728",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-008^4277^6688^^",
      "Patient ID": "001-008",
      "Accession Number": "0",
      "Study Date": "20110718",
      "parameters": [
        {
          "Case Number": "30",
          "Enrollment Date": "20110222",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-008^4277^6688^^",
      "Patient ID": "001-008",
      "Accession Number": "0",
      "Study Date": "20110308",
      "parameters": [
        {
          "Case Number": "30",
          "Enrollment Date": "20110222",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-008^4277^6688^^",
      "Patient ID": "001-008",
      "Accession Number": "0",
      "Study Date": "20110222",
      "parameters": [
        {
          "Case Number": "30",
          "Enrollment Date": "20110222",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-009^4277^6688^^",
      "Patient ID": "001-009",
      "Accession Number": "0",
      "Study Date": "20111128",
      "parameters": [
        {
          "Case Number": "42",
          "Enrollment Date": "20110517",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-009^4277^6688^^",
      "Patient ID": "001-009",
      "Accession Number": "0",
      "Study Date": "20110607",
      "parameters": [
        {
          "Case Number": "42",
          "Enrollment Date": "20110517",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-009^4277^6688^^",
      "Patient ID": "001-009",
      "Accession Number": "0",
      "Study Date": "20110517",
      "parameters": [
        {
          "Case Number": "42",
          "Enrollment Date": "20110517",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-010^4277^6688^^",
      "Patient ID": "001-010",
      "Accession Number": "0",
      "Study Date": "20120419",
      "parameters": [
        {
          "Case Number": "70",
          "Enrollment Date": "20111215",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-010^4277^6688^^",
      "Patient ID": "001-010",
      "Accession Number": "0",
      "Study Date": "20111221",
      "parameters": [
        {
          "Case Number": "70",
          "Enrollment Date": "20111215",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-010^4277^6688^^",
      "Patient ID": "001-010",
      "Accession Number": "0",
      "Study Date": "20111215",
      "parameters": [
        {
          "Case Number": "70",
          "Enrollment Date": "20111215",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-011^4277^6688^^",
      "Patient ID": "001-011",
      "Accession Number": "0",
      "Study Date": "20120412",
      "parameters": [
        {
          "Case Number": "80",
          "Enrollment Date": "20120322",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "001-011^4277^6688^^",
      "Patient ID": "001-011",
      "Accession Number": "0",
      "Study Date": "20120322",
      "parameters": [
        {
          "Case Number": "80",
          "Enrollment Date": "20120322",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4277",
          "Site Name": "Virginia Commonwealth University/Massey Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-001^4221^6688^^",
      "Patient ID": "002-001",
      "Accession Number": "0",
      "Study Date": "20110401",
      "parameters": [
        {
          "Case Number": "14",
          "Enrollment Date": "20100924",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-001^4221^6688^^",
      "Patient ID": "002-001",
      "Accession Number": "0",
      "Study Date": "20101013",
      "parameters": [
        {
          "Case Number": "14",
          "Enrollment Date": "20100924",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-001^4221^6688^^",
      "Patient ID": "002-001",
      "Accession Number": "0",
      "Study Date": "20101001",
      "parameters": [
        {
          "Case Number": "14",
          "Enrollment Date": "20100924",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-001^4221^6688^^",
      "Patient ID": "002-001",
      "Accession Number": "0",
      "Study Date": "20100930",
      "parameters": [
        {
          "Case Number": "14",
          "Enrollment Date": "20100924",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-002^4221^6688^^",
      "Patient ID": "002-002",
      "Accession Number": "0",
      "Study Date": "20101022",
      "parameters": [
        {
          "Case Number": "18",
          "Enrollment Date": "20101012",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-002^4221^6688^^",
      "Patient ID": "002-002",
      "Accession Number": "0",
      "Study Date": "20101020",
      "parameters": [
        {
          "Case Number": "18",
          "Enrollment Date": "20101012",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-003^4221^6688^^",
      "Patient ID": "002-003",
      "Accession Number": "0",
      "Study Date": "20110331",
      "parameters": [
        {
          "Case Number": "19",
          "Enrollment Date": "20101020",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-003^4221^6688^^",
      "Patient ID": "002-003",
      "Accession Number": "0",
      "Study Date": "20101105",
      "parameters": [
        {
          "Case Number": "19",
          "Enrollment Date": "20101020",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-003^4221^6688^^",
      "Patient ID": "002-003",
      "Accession Number": "0",
      "Study Date": "20101028",
      "parameters": [
        {
          "Case Number": "19",
          "Enrollment Date": "20101020",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-003^4221^6688^^",
      "Patient ID": "002-003",
      "Accession Number": "0",
      "Study Date": "20101015",
      "parameters": [
        {
          "Case Number": "19",
          "Enrollment Date": "20101020",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-004^4221^6688^^",
      "Patient ID": "002-004",
      "Accession Number": "0",
      "Study Date": "20110624",
      "parameters": [
        {
          "Case Number": "23",
          "Enrollment Date": "20101228",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-004^4221^6688^^",
      "Patient ID": "002-004",
      "Accession Number": "0",
      "Study Date": "20110204",
      "parameters": [
        {
          "Case Number": "23",
          "Enrollment Date": "20101228",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-004^4221^6688^^",
      "Patient ID": "002-004",
      "Accession Number": "0",
      "Study Date": "20110114",
      "parameters": [
        {
          "Case Number": "23",
          "Enrollment Date": "20101228",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-004^4221^6688^^",
      "Patient ID": "002-004",
      "Accession Number": "0",
      "Study Date": "20110113",
      "parameters": [
        {
          "Case Number": "23",
          "Enrollment Date": "20101228",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-005^4221^6688^^",
      "Patient ID": "002-005",
      "Accession Number": "0",
      "Study Date": "20110721",
      "parameters": [
        {
          "Case Number": "31",
          "Enrollment Date": "20110302",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-005^4221^6688^^",
      "Patient ID": "002-005",
      "Accession Number": "0",
      "Study Date": "20110407",
      "parameters": [
        {
          "Case Number": "31",
          "Enrollment Date": "20110302",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-005^4221^6688^^",
      "Patient ID": "002-005",
      "Accession Number": "0",
      "Study Date": "20110318",
      "parameters": [
        {
          "Case Number": "31",
          "Enrollment Date": "20110302",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-007^4221^6688^^",
      "Patient ID": "002-007",
      "Accession Number": "0",
      "Study Date": "20111117",
      "parameters": [
        {
          "Case Number": "44",
          "Enrollment Date": "20110607",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-007^4221^6688^^",
      "Patient ID": "002-007",
      "Accession Number": "0",
      "Study Date": "20110623",
      "parameters": [
        {
          "Case Number": "44",
          "Enrollment Date": "20110607",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-007^4221^6688^^",
      "Patient ID": "002-007",
      "Accession Number": "0",
      "Study Date": "20110609",
      "parameters": [
        {
          "Case Number": "44",
          "Enrollment Date": "20110607",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-008^4221^6688^^",
      "Patient ID": "002-008",
      "Accession Number": "0",
      "Study Date": "20111013",
      "parameters": [
        {
          "Case Number": "45",
          "Enrollment Date": "20110615",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-008^4221^6688^^",
      "Patient ID": "002-008",
      "Accession Number": "0",
      "Study Date": "20110623",
      "parameters": [
        {
          "Case Number": "45",
          "Enrollment Date": "20110615",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "002-008^4221^6688^^",
      "Patient ID": "002-008",
      "Accession Number": "0",
      "Study Date": "20110615",
      "parameters": [
        {
          "Case Number": "45",
          "Enrollment Date": "20110615",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4221",
          "Site Name": "University of Washington Medical Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-001^4202^6688^^",
      "Patient ID": "003-001",
      "Accession Number": "0",
      "Study Date": "20100715",
      "parameters": [
        {
          "Case Number": "7",
          "Enrollment Date": "20100719",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-002^4202^6688^^",
      "Patient ID": "003-002",
      "Accession Number": "0",
      "Study Date": "20110328",
      "parameters": [
        {
          "Case Number": "33",
          "Enrollment Date": "20110314",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-002^4202^6688^^",
      "Patient ID": "003-002",
      "Accession Number": "0",
      "Study Date": "20110314",
      "parameters": [
        {
          "Case Number": "33",
          "Enrollment Date": "20110314",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-003^4202^6688^^",
      "Patient ID": "003-003",
      "Accession Number": "0",
      "Study Date": "20111006",
      "parameters": [
        {
          "Case Number": "38",
          "Enrollment Date": "20110407",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-003^4202^6688^^",
      "Patient ID": "003-003",
      "Accession Number": "0",
      "Study Date": "20110502",
      "parameters": [
        {
          "Case Number": "38",
          "Enrollment Date": "20110407",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-003^4202^6688^^",
      "Patient ID": "003-003",
      "Accession Number": "0",
      "Study Date": "20110407",
      "parameters": [
        {
          "Case Number": "38",
          "Enrollment Date": "20110407",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-004^4202^6688^^",
      "Patient ID": "003-004",
      "Accession Number": "0",
      "Study Date": "20111020",
      "parameters": [
        {
          "Case Number": "39",
          "Enrollment Date": "20110426",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-004^4202^6688^^",
      "Patient ID": "003-004",
      "Accession Number": "0",
      "Study Date": "20110512",
      "parameters": [
        {
          "Case Number": "39",
          "Enrollment Date": "20110426",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-004^4202^6688^^",
      "Patient ID": "003-004",
      "Accession Number": "0",
      "Study Date": "20110426",
      "parameters": [
        {
          "Case Number": "39",
          "Enrollment Date": "20110426",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-005^4202^6688^^",
      "Patient ID": "003-005",
      "Accession Number": "0",
      "Study Date": "20110506",
      "parameters": [
        {
          "Case Number": "40",
          "Enrollment Date": "20110427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-005^4202^6688^^",
      "Patient ID": "003-005",
      "Accession Number": "0",
      "Study Date": "20110427",
      "parameters": [
        {
          "Case Number": "40",
          "Enrollment Date": "20110427",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-006^4202^6688^^",
      "Patient ID": "003-006",
      "Accession Number": "0",
      "Study Date": "20120130",
      "parameters": [
        {
          "Case Number": "49",
          "Enrollment Date": "20110720",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-006^4202^6688^^",
      "Patient ID": "003-006",
      "Accession Number": "0",
      "Study Date": "20110818",
      "parameters": [
        {
          "Case Number": "49",
          "Enrollment Date": "20110720",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-006^4202^6688^^",
      "Patient ID": "003-006",
      "Accession Number": "0",
      "Study Date": "20110720",
      "parameters": [
        {
          "Case Number": "49",
          "Enrollment Date": "20110720",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-007^4202^6688^^",
      "Patient ID": "003-007",
      "Accession Number": "0",
      "Study Date": "20110804",
      "parameters": [
        {
          "Case Number": "50",
          "Enrollment Date": "20110726",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-007^4202^6688^^",
      "Patient ID": "003-007",
      "Accession Number": "0",
      "Study Date": "20110726",
      "parameters": [
        {
          "Case Number": "50",
          "Enrollment Date": "20110726",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-009^4202^6688^^",
      "Patient ID": "003-009",
      "Accession Number": "0",
      "Study Date": "20120228",
      "parameters": [
        {
          "Case Number": "52",
          "Enrollment Date": "20110819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-009^4202^6688^^",
      "Patient ID": "003-009",
      "Accession Number": "0",
      "Study Date": "20110825",
      "parameters": [
        {
          "Case Number": "52",
          "Enrollment Date": "20110819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-010^4202^6688^^",
      "Patient ID": "003-010",
      "Accession Number": "0",
      "Study Date": "20120221",
      "parameters": [
        {
          "Case Number": "77",
          "Enrollment Date": "20120217",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "003-011^4202^6688^^",
      "Patient ID": "003-011",
      "Accession Number": "0",
      "Study Date": "20120501",
      "parameters": [
        {
          "Case Number": "84",
          "Enrollment Date": "20120501",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4202",
          "Site Name": "Hospital of The University of Pennsylvania",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-001^4477^6688^^",
      "Patient ID": "004-001",
      "Accession Number": "0",
      "Study Date": "20100722",
      "parameters": [
        {
          "Case Number": "8",
          "Enrollment Date": "20100722",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-001^4477^6688^^",
      "Patient ID": "004-001",
      "Accession Number": "0",
      "Study Date": "20100713",
      "parameters": [
        {
          "Case Number": "8",
          "Enrollment Date": "20100722",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-002^4477^6688^^",
      "Patient ID": "004-002",
      "Accession Number": "0",
      "Study Date": "20110405",
      "parameters": [
        {
          "Case Number": "22",
          "Enrollment Date": "20101130",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-002^4477^6688^^",
      "Patient ID": "004-002",
      "Accession Number": "0",
      "Study Date": "20101220",
      "parameters": [
        {
          "Case Number": "22",
          "Enrollment Date": "20101130",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-002^4477^6688^^",
      "Patient ID": "004-002",
      "Accession Number": "0",
      "Study Date": "20101209",
      "parameters": [
        {
          "Case Number": "22",
          "Enrollment Date": "20101130",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-002^4477^6688^^",
      "Patient ID": "004-002",
      "Accession Number": "0",
      "Study Date": "20101123",
      "parameters": [
        {
          "Case Number": "22",
          "Enrollment Date": "20101130",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-003^4477^6688^^",
      "Patient ID": "004-003",
      "Accession Number": "0",
      "Study Date": "20120228",
      "parameters": [
        {
          "Case Number": "78",
          "Enrollment Date": "20120222",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "004-003^4477^6688^^",
      "Patient ID": "004-003",
      "Accession Number": "0",
      "Study Date": "20120217",
      "parameters": [
        {
          "Case Number": "78",
          "Enrollment Date": "20120222",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4477",
          "Site Name": "Mount Sinai Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-001^4212^6688^^",
      "Patient ID": "005-001",
      "Accession Number": "0",
      "Study Date": "20110207",
      "parameters": [
        {
          "Case Number": "10",
          "Enrollment Date": "20100819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-001^4212^6688^^",
      "Patient ID": "005-001",
      "Accession Number": "0",
      "Study Date": "20100902",
      "parameters": [
        {
          "Case Number": "10",
          "Enrollment Date": "20100819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-001^4212^6688^^",
      "Patient ID": "005-001",
      "Accession Number": "0",
      "Study Date": "20100819",
      "parameters": [
        {
          "Case Number": "10",
          "Enrollment Date": "20100819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-002^4212^6688^^",
      "Patient ID": "005-002",
      "Accession Number": "0",
      "Study Date": "20110208",
      "parameters": [
        {
          "Case Number": "11",
          "Enrollment Date": "20100824",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-002^4212^6688^^",
      "Patient ID": "005-002",
      "Accession Number": "0",
      "Study Date": "20101001",
      "parameters": [
        {
          "Case Number": "11",
          "Enrollment Date": "20100824",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-002^4212^6688^^",
      "Patient ID": "005-002",
      "Accession Number": "0",
      "Study Date": "20100825",
      "parameters": [
        {
          "Case Number": "11",
          "Enrollment Date": "20100824",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-004^4212^6688^^",
      "Patient ID": "005-004",
      "Accession Number": "0",
      "Study Date": "20111005",
      "parameters": [
        {
          "Case Number": "59",
          "Enrollment Date": "20111005",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-005^4212^6688^^",
      "Patient ID": "005-005",
      "Accession Number": "0",
      "Study Date": "20121121",
      "parameters": [
        {
          "Case Number": "86",
          "Enrollment Date": "20120711",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-005^4212^6688^^",
      "Patient ID": "005-005",
      "Accession Number": "0",
      "Study Date": "20120720",
      "parameters": [
        {
          "Case Number": "86",
          "Enrollment Date": "20120711",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005-005^4212^6688^^",
      "Patient ID": "005-005",
      "Accession Number": "0",
      "Study Date": "20120711",
      "parameters": [
        {
          "Case Number": "86",
          "Enrollment Date": "20120711",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "005.001^4212^6688^^",
      "Patient ID": "005.001",
      "Accession Number": "0",
      "Study Date": "20100819",
      "parameters": [
        {
          "Case Number": "10",
          "Enrollment Date": "20100819",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4212",
          "Site Name": "Thomas Jefferson University Hospital",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "006-001^4205^6688^^",
      "Patient ID": "006-001",
      "Accession Number": "0",
      "Study Date": "20111213",
      "parameters": [
        {
          "Case Number": "67",
          "Enrollment Date": "20111213",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4205",
          "Site Name": "Washington University School of Medicine",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "006_001^4205^6688^^",
      "Patient ID": "006_001",
      "Accession Number": "0",
      "Study Date": "20111223",
      "parameters": [
        {
          "Case Number": "67",
          "Enrollment Date": "20111213",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4205",
          "Site Name": "Washington University School of Medicine",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-001^4303^6688^^",
      "Patient ID": "007-001",
      "Accession Number": "0",
      "Study Date": "20110322",
      "parameters": [
        {
          "Case Number": "17",
          "Enrollment Date": "20101001",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-001^4303^6688^^",
      "Patient ID": "007-001",
      "Accession Number": "0",
      "Study Date": "20101013",
      "parameters": [
        {
          "Case Number": "17",
          "Enrollment Date": "20101001",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-001^4303^6688^^",
      "Patient ID": "007-001",
      "Accession Number": "0",
      "Study Date": "20101005",
      "parameters": [
        {
          "Case Number": "17",
          "Enrollment Date": "20101001",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-002^4303^6688^^",
      "Patient ID": "007-002",
      "Accession Number": "0",
      "Study Date": "20111025",
      "parameters": [
        {
          "Case Number": "35",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-002^4303^6688^^",
      "Patient ID": "007-002",
      "Accession Number": "0",
      "Study Date": "20110422",
      "parameters": [
        {
          "Case Number": "35",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "007-002^4303^6688^^",
      "Patient ID": "007-002",
      "Accession Number": "0",
      "Study Date": "20110411",
      "parameters": [
        {
          "Case Number": "35",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4303",
          "Site Name": "Scottsdale Healthcare Osborn",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-001^4445^6688^^",
      "Patient ID": "008-001",
      "Accession Number": "0",
      "Study Date": "20110117",
      "parameters": [
        {
          "Case Number": "12",
          "Enrollment Date": "20100812",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-001^4445^6688^^",
      "Patient ID": "008-001",
      "Accession Number": "0",
      "Study Date": "20100826",
      "parameters": [
        {
          "Case Number": "12",
          "Enrollment Date": "20100812",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-001^4445^6688^^",
      "Patient ID": "008-001",
      "Accession Number": "0",
      "Study Date": "20100812",
      "parameters": [
        {
          "Case Number": "12",
          "Enrollment Date": "20100812",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-002^4445^6688^^",
      "Patient ID": "008-002",
      "Accession Number": "0",
      "Study Date": "20101221",
      "parameters": [
        {
          "Case Number": "13",
          "Enrollment Date": "20100827",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-002^4445^6688^^",
      "Patient ID": "008-002",
      "Accession Number": "0",
      "Study Date": "20100907",
      "parameters": [
        {
          "Case Number": "13",
          "Enrollment Date": "20100827",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-002^4445^6688^^",
      "Patient ID": "008-002",
      "Accession Number": "0",
      "Study Date": "20100827",
      "parameters": [
        {
          "Case Number": "13",
          "Enrollment Date": "20100827",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-003^4445^6688^^",
      "Patient ID": "008-003",
      "Accession Number": "0",
      "Study Date": "20101228",
      "parameters": [
        {
          "Case Number": "15",
          "Enrollment Date": "20100915",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-003^4445^6688^^",
      "Patient ID": "008-003",
      "Accession Number": "0",
      "Study Date": "20100930",
      "parameters": [
        {
          "Case Number": "15",
          "Enrollment Date": "20100915",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-003^4445^6688^^",
      "Patient ID": "008-003",
      "Accession Number": "0",
      "Study Date": "20100916",
      "parameters": [
        {
          "Case Number": "15",
          "Enrollment Date": "20100915",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-004^4445^6688^^",
      "Patient ID": "008-004",
      "Accession Number": "0",
      "Study Date": "20101021",
      "parameters": [
        {
          "Case Number": "16",
          "Enrollment Date": "20100921",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-004^4445^6688^^",
      "Patient ID": "008-004",
      "Accession Number": "0",
      "Study Date": "20100921",
      "parameters": [
        {
          "Case Number": "16",
          "Enrollment Date": "20100921",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-005^4445^6688^^",
      "Patient ID": "008-005",
      "Accession Number": "0",
      "Study Date": "20110308",
      "parameters": [
        {
          "Case Number": "24",
          "Enrollment Date": "20101011",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-005^4445^6688^^",
      "Patient ID": "008-005",
      "Accession Number": "0",
      "Study Date": "20101028",
      "parameters": [
        {
          "Case Number": "24",
          "Enrollment Date": "20101011",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-005^4445^6688^^",
      "Patient ID": "008-005",
      "Accession Number": "0",
      "Study Date": "20101011",
      "parameters": [
        {
          "Case Number": "24",
          "Enrollment Date": "20101011",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-006^4445^6688^^",
      "Patient ID": "008-006",
      "Accession Number": "0",
      "Study Date": "20101118",
      "parameters": [
        {
          "Case Number": "25",
          "Enrollment Date": "20101021",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-006^4445^6688^^",
      "Patient ID": "008-006",
      "Accession Number": "0",
      "Study Date": "20101021",
      "parameters": [
        {
          "Case Number": "25",
          "Enrollment Date": "20101021",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-007^4445^6688^^",
      "Patient ID": "008-007",
      "Accession Number": "0",
      "Study Date": "20110331",
      "parameters": [
        {
          "Case Number": "20",
          "Enrollment Date": "20101025",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-007^4445^6688^^",
      "Patient ID": "008-007",
      "Accession Number": "0",
      "Study Date": "20101115",
      "parameters": [
        {
          "Case Number": "20",
          "Enrollment Date": "20101025",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "008-007^4445^6688^^",
      "Patient ID": "008-007",
      "Accession Number": "0",
      "Study Date": "20101025",
      "parameters": [
        {
          "Case Number": "20",
          "Enrollment Date": "20101025",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4445",
          "Site Name": "Excel Diagnostics Imaging Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "009-001^4495^6688^^",
      "Patient ID": "009-001",
      "Accession Number": "0",
      "Study Date": "20130225",
      "parameters": [
        {
          "Case Number": "90",
          "Enrollment Date": "20120821",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4495",
          "Site Name": "Fox Chase Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "009-001^4495^6688^^",
      "Patient ID": "009-001",
      "Accession Number": "0",
      "Study Date": "20120829",
      "parameters": [
        {
          "Case Number": "90",
          "Enrollment Date": "20120821",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4495",
          "Site Name": "Fox Chase Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "009-001^4495^6688^^",
      "Patient ID": "009-001",
      "Accession Number": "0",
      "Study Date": "20120822",
      "parameters": [
        {
          "Case Number": "90",
          "Enrollment Date": "20120821",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4495",
          "Site Name": "Fox Chase Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-001^4216^6688^^",
      "Patient ID": "010-001",
      "Accession Number": "0",
      "Study Date": "20110516",
      "parameters": [
        {
          "Case Number": "28",
          "Enrollment Date": "20110121",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-001^4216^6688^^",
      "Patient ID": "010-001",
      "Accession Number": "0",
      "Study Date": "20110203",
      "parameters": [
        {
          "Case Number": "28",
          "Enrollment Date": "20110121",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-001^4216^6688^^",
      "Patient ID": "010-001",
      "Accession Number": "0",
      "Study Date": "20110121",
      "parameters": [
        {
          "Case Number": "28",
          "Enrollment Date": "20110121",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-002^4216^6688^^",
      "Patient ID": "010-002",
      "Accession Number": "0",
      "Study Date": "20110725",
      "parameters": [
        {
          "Case Number": "29",
          "Enrollment Date": "20110210",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-002^4216^6688^^",
      "Patient ID": "010-002",
      "Accession Number": "0",
      "Study Date": "20110225",
      "parameters": [
        {
          "Case Number": "29",
          "Enrollment Date": "20110210",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "010-002^4216^6688^^",
      "Patient ID": "010-002",
      "Accession Number": "0",
      "Study Date": "20110210",
      "parameters": [
        {
          "Case Number": "29",
          "Enrollment Date": "20110210",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4216",
          "Site Name": "UNC Lineberger Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-001^4317^6688^^",
      "Patient ID": "011-001",
      "Accession Number": "0",
      "Study Date": "20110825",
      "parameters": [
        {
          "Case Number": "51",
          "Enrollment Date": "20110823",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-002^4317^6688^^",
      "Patient ID": "011-002",
      "Accession Number": "0",
      "Study Date": "20110906",
      "parameters": [
        {
          "Case Number": "53",
          "Enrollment Date": "20110906",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-003^4317^6688^^",
      "Patient ID": "011-003",
      "Accession Number": "0",
      "Study Date": "20120202",
      "parameters": [
        {
          "Case Number": "54",
          "Enrollment Date": "20110916",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-003^4317^6688^^",
      "Patient ID": "011-003",
      "Accession Number": "0",
      "Study Date": "20111011",
      "parameters": [
        {
          "Case Number": "54",
          "Enrollment Date": "20110916",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-003^4317^6688^^",
      "Patient ID": "011-003",
      "Accession Number": "0",
      "Study Date": "20110920",
      "parameters": [
        {
          "Case Number": "54",
          "Enrollment Date": "20110916",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-004^4317^6688^^",
      "Patient ID": "011-004",
      "Accession Number": "0",
      "Study Date": "20120323",
      "parameters": [
        {
          "Case Number": "60",
          "Enrollment Date": "20111007",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-004^4317^6688^^",
      "Patient ID": "011-004",
      "Accession Number": "0",
      "Study Date": "20111027",
      "parameters": [
        {
          "Case Number": "60",
          "Enrollment Date": "20111007",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-004^4317^6688^^",
      "Patient ID": "011-004",
      "Accession Number": "0",
      "Study Date": "20111007",
      "parameters": [
        {
          "Case Number": "60",
          "Enrollment Date": "20111007",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-006^4317^6688^^",
      "Patient ID": "011-006",
      "Accession Number": "0",
      "Study Date": "20111012",
      "parameters": [
        {
          "Case Number": "58",
          "Enrollment Date": "20111003",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-007^4317^6688^^",
      "Patient ID": "011-007",
      "Accession Number": "0",
      "Study Date": "20120604",
      "parameters": [
        {
          "Case Number": "62",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-007^4317^6688^^",
      "Patient ID": "011-007",
      "Accession Number": "0",
      "Study Date": "20111121",
      "parameters": [
        {
          "Case Number": "62",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-007^4317^6688^^",
      "Patient ID": "011-007",
      "Accession Number": "0",
      "Study Date": "20111114",
      "parameters": [
        {
          "Case Number": "62",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-008^4317^6688^^",
      "Patient ID": "011-008",
      "Accession Number": "0",
      "Study Date": "20111115",
      "parameters": [
        {
          "Case Number": "63",
          "Enrollment Date": "20111115",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-009^4317^6688^^",
      "Patient ID": "011-009",
      "Accession Number": "0",
      "Study Date": "20120105",
      "parameters": [
        {
          "Case Number": "72",
          "Enrollment Date": "20111229",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-010^4317^6688^^",
      "Patient ID": "011-010",
      "Accession Number": "0",
      "Study Date": "20120229",
      "parameters": [
        {
          "Case Number": "76",
          "Enrollment Date": "20120213",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-010^4317^6688^^",
      "Patient ID": "011-010",
      "Accession Number": "0",
      "Study Date": "20120213",
      "parameters": [
        {
          "Case Number": "76",
          "Enrollment Date": "20120213",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-011^4317^6688^^",
      "Patient ID": "011-011",
      "Accession Number": "0",
      "Study Date": "20120405",
      "parameters": [
        {
          "Case Number": "79",
          "Enrollment Date": "20120221",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-011^4317^6688^^",
      "Patient ID": "011-011",
      "Accession Number": "0",
      "Study Date": "20120221",
      "parameters": [
        {
          "Case Number": "79",
          "Enrollment Date": "20120221",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-012^4317^6688^^",
      "Patient ID": "011-012",
      "Accession Number": "0",
      "Study Date": "20120404",
      "parameters": [
        {
          "Case Number": "83",
          "Enrollment Date": "20120326",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "011-012^4317^6688^^",
      "Patient ID": "011-012",
      "Accession Number": "0",
      "Study Date": "20120326",
      "parameters": [
        {
          "Case Number": "83",
          "Enrollment Date": "20120326",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4317",
          "Site Name": "USC / Norris Comprehensive Cancer Center",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-001^4311^6688^^",
      "Patient ID": "012-001",
      "Accession Number": "0",
      "Study Date": "20110916",
      "parameters": [
        {
          "Case Number": "41",
          "Enrollment Date": "20110518",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-001^4311^6688^^",
      "Patient ID": "012-001",
      "Accession Number": "0",
      "Study Date": "20110609",
      "parameters": [
        {
          "Case Number": "41",
          "Enrollment Date": "20110518",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-001^4311^6688^^",
      "Patient ID": "012-001",
      "Accession Number": "0",
      "Study Date": "20110520",
      "parameters": [
        {
          "Case Number": "41",
          "Enrollment Date": "20110518",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-001^4311^6688^^",
      "Patient ID": "012-001",
      "Accession Number": "0",
      "Study Date": "20110513",
      "parameters": [
        {
          "Case Number": "41",
          "Enrollment Date": "20110518",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-002^4311^6688^^",
      "Patient ID": "012-002",
      "Accession Number": "0",
      "Study Date": "20110603",
      "parameters": [
        {
          "Case Number": "43",
          "Enrollment Date": "20110525",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-002^4311^6688^^",
      "Patient ID": "012-002",
      "Accession Number": "0",
      "Study Date": "20110525",
      "parameters": [
        {
          "Case Number": "43",
          "Enrollment Date": "20110525",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-002^4311^6688^^",
      "Patient ID": "012-002",
      "Accession Number": "0",
      "Study Date": "20110512",
      "parameters": [
        {
          "Case Number": "43",
          "Enrollment Date": "20110525",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-003^4311^6688^^",
      "Patient ID": "012-003",
      "Accession Number": "0",
      "Study Date": "20111101",
      "parameters": [
        {
          "Case Number": "48",
          "Enrollment Date": "20110630",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-003^4311^6688^^",
      "Patient ID": "012-003",
      "Accession Number": "0",
      "Study Date": "20110715",
      "parameters": [
        {
          "Case Number": "48",
          "Enrollment Date": "20110630",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "012-003^4311^6688^^",
      "Patient ID": "012-003",
      "Accession Number": "0",
      "Study Date": "20110707",
      "parameters": [
        {
          "Case Number": "48",
          "Enrollment Date": "20110630",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4311",
          "Site Name": "University of Arkansas for Medical Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-001^4227^6688^^",
      "Patient ID": "014-001",
      "Accession Number": "0",
      "Study Date": "20110301",
      "parameters": [
        {
          "Case Number": "21",
          "Enrollment Date": "20101029",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-001^4227^6688^^",
      "Patient ID": "014-001",
      "Accession Number": "0",
      "Study Date": "20101115",
      "parameters": [
        {
          "Case Number": "21",
          "Enrollment Date": "20101029",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-001^4227^6688^^",
      "Patient ID": "014-001",
      "Accession Number": "0",
      "Study Date": "20101104",
      "parameters": [
        {
          "Case Number": "21",
          "Enrollment Date": "20101029",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-002^4227^6688^^",
      "Patient ID": "014-002",
      "Accession Number": "0",
      "Study Date": "20110118",
      "parameters": [
        {
          "Case Number": "26",
          "Enrollment Date": "20110104",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-002^4227^6688^^",
      "Patient ID": "014-002",
      "Accession Number": "0",
      "Study Date": "20110104",
      "parameters": [
        {
          "Case Number": "26",
          "Enrollment Date": "20110104",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-003^4227^6688^^",
      "Patient ID": "014-003",
      "Accession Number": "0",
      "Study Date": "20110502",
      "parameters": [
        {
          "Case Number": "37",
          "Enrollment Date": "20110418",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "014-003^4227^6688^^",
      "Patient ID": "014-003",
      "Accession Number": "0",
      "Study Date": "20110418",
      "parameters": [
        {
          "Case Number": "37",
          "Enrollment Date": "20110418",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4227",
          "Site Name": "Wake Forest University Health Sciences",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-001^4244^6688^^",
      "Patient ID": "016-001",
      "Accession Number": "0",
      "Study Date": "20110729",
      "parameters": [
        {
          "Case Number": "34",
          "Enrollment Date": "20110331",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-001^4244^6688^^",
      "Patient ID": "016-001",
      "Accession Number": "0",
      "Study Date": "20110408",
      "parameters": [
        {
          "Case Number": "34",
          "Enrollment Date": "20110331",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-001^4244^6688^^",
      "Patient ID": "016-001",
      "Accession Number": "0",
      "Study Date": "20110331",
      "parameters": [
        {
          "Case Number": "34",
          "Enrollment Date": "20110331",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-002^4244^6688^^",
      "Patient ID": "016-002",
      "Accession Number": "0",
      "Study Date": "20110915",
      "parameters": [
        {
          "Case Number": "36",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-002^4244^6688^^",
      "Patient ID": "016-002",
      "Accession Number": "0",
      "Study Date": "20110422",
      "parameters": [
        {
          "Case Number": "36",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "016-002^4244^6688^^",
      "Patient ID": "016-002",
      "Accession Number": "0",
      "Study Date": "20110411",
      "parameters": [
        {
          "Case Number": "36",
          "Enrollment Date": "20110411",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4244",
          "Site Name": "Medical University of South Carolina",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-001^4346^6688^^",
      "Patient ID": "017-001",
      "Accession Number": "0",
      "Study Date": "20110518",
      "parameters": [
        {
          "Case Number": "27",
          "Enrollment Date": "20110118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-001^4346^6688^^",
      "Patient ID": "017-001",
      "Accession Number": "0",
      "Study Date": "20110126",
      "parameters": [
        {
          "Case Number": "27",
          "Enrollment Date": "20110118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-001^4346^6688^^",
      "Patient ID": "017-001",
      "Accession Number": "0",
      "Study Date": "20110119",
      "parameters": [
        {
          "Case Number": "27",
          "Enrollment Date": "20110118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-002^4346^6688^^",
      "Patient ID": "017-002",
      "Accession Number": "0",
      "Study Date": "20120409",
      "parameters": [
        {
          "Case Number": "64",
          "Enrollment Date": "20111128",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-002^4346^6688^^",
      "Patient ID": "017-002",
      "Accession Number": "0",
      "Study Date": "20111213",
      "parameters": [
        {
          "Case Number": "64",
          "Enrollment Date": "20111128",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-002^4346^6688^^",
      "Patient ID": "017-002",
      "Accession Number": "0",
      "Study Date": "20111130",
      "parameters": [
        {
          "Case Number": "64",
          "Enrollment Date": "20111128",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-003^4346^6688^^",
      "Patient ID": "017-003",
      "Accession Number": "0",
      "Study Date": "20120509",
      "parameters": [
        {
          "Case Number": "66",
          "Enrollment Date": "20111209",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-003^4346^6688^^",
      "Patient ID": "017-003",
      "Accession Number": "0",
      "Study Date": "20111229",
      "parameters": [
        {
          "Case Number": "66",
          "Enrollment Date": "20111209",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-003^4346^6688^^",
      "Patient ID": "017-003",
      "Accession Number": "0",
      "Study Date": "20111214",
      "parameters": [
        {
          "Case Number": "66",
          "Enrollment Date": "20111209",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-004^4346^6688^^",
      "Patient ID": "017-004",
      "Accession Number": "0",
      "Study Date": "20120605",
      "parameters": [
        {
          "Case Number": "82",
          "Enrollment Date": "20120403",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-004^4346^6688^^",
      "Patient ID": "017-004",
      "Accession Number": "0",
      "Study Date": "20120416",
      "parameters": [
        {
          "Case Number": "82",
          "Enrollment Date": "20120403",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "017-004^4346^6688^^",
      "Patient ID": "017-004",
      "Accession Number": "0",
      "Study Date": "20120405",
      "parameters": [
        {
          "Case Number": "82",
          "Enrollment Date": "20120403",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4346",
          "Site Name": "University of Wisconsin Hospital and Clinics",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-001^4428^6688^^",
      "Patient ID": "018-001",
      "Accession Number": "0",
      "Study Date": "20110627",
      "parameters": [
        {
          "Case Number": "47",
          "Enrollment Date": "20110624",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-002^4428^6688^^",
      "Patient ID": "018-002",
      "Accession Number": "0",
      "Study Date": "20120308",
      "parameters": [
        {
          "Case Number": "57",
          "Enrollment Date": "20111003",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-002^4428^6688^^",
      "Patient ID": "018-002",
      "Accession Number": "0",
      "Study Date": "20111026",
      "parameters": [
        {
          "Case Number": "57",
          "Enrollment Date": "20111003",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-002^4428^6688^^",
      "Patient ID": "018-002",
      "Accession Number": "0",
      "Study Date": "20111006",
      "parameters": [
        {
          "Case Number": "57",
          "Enrollment Date": "20111003",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-003^4428^6688^^",
      "Patient ID": "018-003",
      "Accession Number": "0",
      "Study Date": "20120315",
      "parameters": [
        {
          "Case Number": "61",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-003^4428^6688^^",
      "Patient ID": "018-003",
      "Accession Number": "0",
      "Study Date": "20111115",
      "parameters": [
        {
          "Case Number": "61",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-003^4428^6688^^",
      "Patient ID": "018-003",
      "Accession Number": "0",
      "Study Date": "20111104",
      "parameters": [
        {
          "Case Number": "61",
          "Enrollment Date": "20111103",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-005^4428^6688^^",
      "Patient ID": "018-005",
      "Accession Number": "0",
      "Study Date": "20120802",
      "parameters": [
        {
          "Case Number": "69",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-005^4428^6688^^",
      "Patient ID": "018-005",
      "Accession Number": "0",
      "Study Date": "20111230",
      "parameters": [
        {
          "Case Number": "69",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-005^4428^6688^^",
      "Patient ID": "018-005",
      "Accession Number": "0",
      "Study Date": "20111216",
      "parameters": [
        {
          "Case Number": "69",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-006^4428^6688^^",
      "Patient ID": "018-006",
      "Accession Number": "0",
      "Study Date": "20120730",
      "parameters": [
        {
          "Case Number": "75",
          "Enrollment Date": "20120207",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-006^4428^6688^^",
      "Patient ID": "018-006",
      "Accession Number": "0",
      "Study Date": "20120217",
      "parameters": [
        {
          "Case Number": "75",
          "Enrollment Date": "20120207",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-006^4428^6688^^",
      "Patient ID": "018-006",
      "Accession Number": "0",
      "Study Date": "20120208",
      "parameters": [
        {
          "Case Number": "75",
          "Enrollment Date": "20120207",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-007^4428^6688^^",
      "Patient ID": "018-007",
      "Accession Number": "0",
      "Study Date": "20120402",
      "parameters": [
        {
          "Case Number": "81",
          "Enrollment Date": "20120330",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-008^4428^6688^^",
      "Patient ID": "018-008",
      "Accession Number": "0",
      "Study Date": "20121003",
      "parameters": [
        {
          "Case Number": "85",
          "Enrollment Date": "20120705",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-008^4428^6688^^",
      "Patient ID": "018-008",
      "Accession Number": "0",
      "Study Date": "20120726",
      "parameters": [
        {
          "Case Number": "85",
          "Enrollment Date": "20120705",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-008^4428^6688^^",
      "Patient ID": "018-008",
      "Accession Number": "0",
      "Study Date": "20120705",
      "parameters": [
        {
          "Case Number": "85",
          "Enrollment Date": "20120705",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-009^4428^6688^^",
      "Patient ID": "018-009",
      "Accession Number": "0",
      "Study Date": "20121024",
      "parameters": [
        {
          "Case Number": "87",
          "Enrollment Date": "20120717",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-009^4428^6688^^",
      "Patient ID": "018-009",
      "Accession Number": "0",
      "Study Date": "20120731",
      "parameters": [
        {
          "Case Number": "87",
          "Enrollment Date": "20120717",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-009^4428^6688^^",
      "Patient ID": "018-009",
      "Accession Number": "0",
      "Study Date": "20120718",
      "parameters": [
        {
          "Case Number": "87",
          "Enrollment Date": "20120717",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-010^4428^6688^^",
      "Patient ID": "018-010",
      "Accession Number": "0",
      "Study Date": "20130305",
      "parameters": [
        {
          "Case Number": "89",
          "Enrollment Date": "20120817",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-010^4428^6688^^",
      "Patient ID": "018-010",
      "Accession Number": "0",
      "Study Date": "20120830",
      "parameters": [
        {
          "Case Number": "89",
          "Enrollment Date": "20120817",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "018-010^4428^6688^^",
      "Patient ID": "018-010",
      "Accession Number": "0",
      "Study Date": "20120821",
      "parameters": [
        {
          "Case Number": "89",
          "Enrollment Date": "20120817",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4428",
          "Site Name": "Morton Plant Mease",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-001^4476^6688^^",
      "Patient ID": "021-001",
      "Accession Number": "0",
      "Study Date": "20111208",
      "parameters": [
        {
          "Case Number": "46",
          "Enrollment Date": "20110621",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-001^4476^6688^^",
      "Patient ID": "021-001",
      "Accession Number": "0",
      "Study Date": "20110630",
      "parameters": [
        {
          "Case Number": "46",
          "Enrollment Date": "20110621",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-001^4476^6688^^",
      "Patient ID": "021-001",
      "Accession Number": "0",
      "Study Date": "20110621",
      "parameters": [
        {
          "Case Number": "46",
          "Enrollment Date": "20110621",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-002^4476^6688^^",
      "Patient ID": "021-002",
      "Accession Number": "0",
      "Study Date": "20120504",
      "parameters": [
        {
          "Case Number": "71",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-002^4476^6688^^",
      "Patient ID": "021-002",
      "Accession Number": "0",
      "Study Date": "20111229",
      "parameters": [
        {
          "Case Number": "71",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-002^4476^6688^^",
      "Patient ID": "021-002",
      "Accession Number": "0",
      "Study Date": "20111219",
      "parameters": [
        {
          "Case Number": "71",
          "Enrollment Date": "20111216",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-003^4476^6688^^",
      "Patient ID": "021-003",
      "Accession Number": "0",
      "Study Date": "20120711",
      "parameters": [
        {
          "Case Number": "73",
          "Enrollment Date": "20120118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-003^4476^6688^^",
      "Patient ID": "021-003",
      "Accession Number": "0",
      "Study Date": "20120126",
      "parameters": [
        {
          "Case Number": "73",
          "Enrollment Date": "20120118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    },
    {
      "Patient Name": "021-003^4476^6688^^",
      "Patient ID": "021-003",
      "Accession Number": "0",
      "Study Date": "20120118",
      "parameters": [
        {
          "Case Number": "73",
          "Enrollment Date": "20120118",
          "Trial Number": "6688",
          "Trial Name": "PHASE II STUDY OF 3-DEOXY-3-18F FLUOROTHYMIDINE (FLT) IN INVASIVE BREAST CNCR",
          "Site Number": "4476",
          "Site Name": "Wayne State University/Karmanos Cancer Institute",
          "Timepoint ID": "",
          "Timepoint Description": "",
          "Submission Type": "Clinical Trial",
          "Additional Trial Input": "",
          "Anonymization Profile": "Safe Harbor/Retain Patient Characteristics/Retain Safe Private",
          "Validation Profile": "",
          "User": "bbialecki"
        }
      ]
    }
  ]
}
